source
- STAT+: An insider reveals the real goals of prior authorizationYears ago, Archelle Georgiou helped squash prior auths at one of America's biggest health insurers.STAT · 3mo ago↗ source
- STAT+: Astellas retries XLMTM gene therapy after deathsVeradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech newsSTAT · 3mo ago↗ source
- STAT+: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and moreIntellia disclosed that a single dose of its gene editing treatment dramatically reduced swelling attacks in patients with hereditary angioedemaSTAT · 3mo ago↗ source